Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Pediatric Enthesitis Related Arthritis
2009-017938-46Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in juvenile idiopathic arthritis, enthesitis-related (JIA-ERA) comparing Adalimumab arm with Placebo arm (2 arms). Primary endpoint: Percent change in number of active joints with arthritis at Week 12. Started Apr 2010; status: completed.
02
Drugs
03
Conditions
juvenile idiopathic arthritis, enthesitis-related (JIA-ERA)
Beyond the preview
Go deeper on 2009-017938-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017938-46.